Data from two systematic reviews and a meta-analysis of randomised controlled trials showed mixed results regarding the effects of ONS on certain markers of NUS in HD patients, e.g., albumin, pre-albumin, MUAMC, TSFT, BMI, and lean mass (4, 5). The gene discussed is ALB; the disease is Huntington disease.